Estimaciones de analistas de Wall Street para Tyson Foods, Inc. (TSN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $0.82 | ||
| 2026-08-03 | $0.99 | $0.99 | +0.1% |
| 2026-05-04 | $0.87 | $0.78 | +11.5% |
| 2026-02-02 | $0.97 | $1.01 | -4.0% |
| 2025-11-10 | $1.15 | $0.84 | +36.9% |
| 2025-08-04 | $0.91 | $0.80 | +13.5% |
| 2025-05-05 | $0.92 | $0.83 | +10.7% |
| 2025-02-03 | $1.14 | $0.90 | +27.1% |
Ratios de valoración
| Ratio P/E | 31.51 |
| Precio / Valor contable | 1.00 |
| EV / EBITDA | 9.89 |
| Rentabilidad por dividendo | 3.88% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $36.88B | $38.26B | $40.05B | $42.41B | $43.19B | $47.05B | $53.28B | $52.88B | $53.31B | $54.44B |
| Coste de Ventas | $32.18B | $33.20B | $34.96B | $37.38B | $37.80B | $40.52B | $46.61B | $50.25B | $49.68B | $50.88B |
| Beneficio Bruto | $4.70B | $5.06B | $5.10B | $5.02B | $5.38B | $6.53B | $6.67B | $2.63B | $3.63B | $3.56B |
| I+D | 0 | 0 | 0 | 0 | 0 | $114.0M | $108.0M | $114.0M | $106.0M | $126.0M |
| Generales y Administrativos | $1.86B | $2.14B | $2.13B | $2.25B | $2.27B | $2.13B | $2.22B | $2.16B | $2.19B | $2.12B |
| Gastos Operativos | $1.86B | $2.14B | $2.13B | $2.25B | $2.38B | $2.13B | $2.26B | $3.03B | $2.22B | $2.12B |
| Beneficio Operativo | $2.83B | $2.92B | $2.97B | $2.77B | $3.01B | $4.40B | $4.41B | -$395.0M | $1.41B | $1.44B |
| EBITDA | $3.55B | $3.67B | $3.98B | $3.93B | $4.34B | $5.68B | $5.72B | $1.02B | $2.97B | $2.58B |
| Gastos por Intereses | $249.0M | $279.0M | $350.0M | $462.0M | $485.0M | $428.0M | $365.0M | $355.0M | $481.0M | $449.0M |
| Beneficio Antes de Impuestos | $2.60B | $2.63B | $2.68B | $2.37B | $2.66B | $4.04B | $4.15B | -$678.0M | $1.09B | $769.0M |
| Impuestos | $826.0M | $850.0M | -$291.0M | $381.0M | $593.0M | $981.0M | $900.0M | -$29.0M | $270.0M | $262.0M |
| Beneficio Neto | $1.77B | $1.77B | $2.97B | $1.98B | $2.06B | $3.05B | $3.24B | -$648.0M | $800.0M | $474.0M |
| BPA | $4.67 | $4.94 | $8.14 | $5.45 | $5.68 | $8.57 | $9.18 | $-1.87 | $2.31 | $1.36 |
| BPA Diluido | $4.53 | $4.79 | $8.04 | $5.52 | $5.64 | $8.34 | $8.92 | $-1.87 | $2.25 | $1.36 |
| Acciones en Circulación (Diluidas) | $390.0M | $370.0M | $369.0M | $366.0M | $365.0M | $365.0M | $363.0M | $354.0M | $356.0M | $348.0M |
Precio
| Precio | $52.77 |
| Capitalización | $18.7B |
| Bolsa | NYSE |
| País | US |
Empresas relacionadas: BG · CHD · DLTR · FMX · KOF · MKC · SFD
Explorar sector: Consumer Defensive · Agricultural Farm Products
Más secciones de TSN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones